Largest Pharmaceutical Misconduct Settlement In History As GSK Fined Over 3 Billion

Largest Pharmaceutical Misconduct Settlement In History As GSK Fined Over 3 Billion
July 4, 2012 | BigPharma | Editor
Pharmaceutical drug maker GlaxoSmithKline PLC will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, misbranding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes